LH · 10-Q · 2026Q3 · Full report
Equity Method Losses
LABCORP HOLDINGS INC. · 2026-10-30 · Importance 45 · Surprise 64 · No source text
Equity method loss, net, increased 109.3% to $11.0 million in the third quarter of 2026 from $5.2 million in the prior-year quarter. For the first nine months, the loss increased 207.3% to $22.3 million from $7.2 million. Labcorp attributed the increases primarily to losses recognized from its SYNLAB investment; the line also includes its ownership share of joint venture partnerships and equity investments in healthcare companies.
Key facts
- Labcorp’s equity method loss was $11.0 million in the three months ended September 30, 2026, compared with $5.2 million in 2025; the increase was primarily due to a loss recognized from its SYNLAB investment. source
- Labcorp’s equity method loss was $22.3 million in the nine months ended September 30, 2026, compared with $7.2 million in 2025; the increase was primarily due to a loss recognized from its SYNLAB investment. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | realized | -0.4% | Labcorp’s equity method loss was $22.3 million in the nine months ended September 30, 2026, compared with $7.2 million in 2025; the… |